Beneficial Effects of Flavonoids Against Parkinson's Disease

Parkinson's disease

Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,412 · see citing works

Chemistry and Biological Activities of Flavonoids: An Overview

Kumar, S., & Pandey, A. K. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/162750 · Cited by 5,178 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K., Holloway, R. G., Kieburtz, K. D., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,479 · see citing works

Health effects of quercetin: From antioxidant to nutraceutical

Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121 · see citing works

Oxidative stress in Parkinson's disease

Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · see citing works

Dietary phenolics: chemistry, bioavailability and effects on health

Crozier, A., Jaganath, I. B., & Clifford, M. N. (2009) · Natural Product Reports · doi:10.1039/b802662a · Cited by 2,002 · see citing works

Parkinson's disease

Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956 · see citing works

The Role of Oxidative Stress in Parkinson's Disease

Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845 · see citing works

The protein kinase B/Akt signalling pathway in human malignancy

Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,631 · see citing works

-Synuclein in Parkinson's Disease

Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446 · see citing works

Distribution and biological activities of the flavonoid luteolin

Lopez-Lazaro, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001712 · Cited by 1,106 · see citing works

Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway

Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,046 · see citing works

Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease

Lang, A. E., Gill, S., Patel, N., Lozano, A., Nutt, J. G., Penn, R., Brooks, D. J., Hotton, G. R., Moro, E., Heywood, P., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20737 · Cited by 987 · see citing works

EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity

Bieschke, J., Russ, J., Friedrich, R., Ehrnhoefer, D. E., Wobst, H. J., Neugebauer, K., & Wanker, E. (2010) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0910723107 · Cited by 986 · see citing works

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883 · see citing works

Role of Oxidative Stress in Parkinson's Disease

Hwang, O. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.11 · Cited by 845 · see citing works

Flavonoids Protect Neuronal Cells from Oxidative Stress by Three Distinct Mechanisms

Ishige, K., Schubert, D., & Sagara, Y. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00498-6 · Cited by 841 · see citing works

Flavonoid Bioavailability and Attempts for Bioavailability Enhancement

Thilakarathna, S. H., & Rupasinghe, H. P. V. (2013) · Nutrients · doi:10.3390/nu5093367 · Cited by 809 · see citing works

Oxidative processes and antioxidative defense mechanisms in the aging brain 1

Reiter, R. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737461 · Cited by 801 · see citing works

Flavonoid permeability across an in situ model of the blood–brain barrier

Youdim, K. A., Qaiser, M. Z., Begley, D. J., Rice-Evans, C. A., & Abbott, N. J. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.023 · Cited by 605 · see citing works

Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N ‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration

Levites, Y., Weinreb, O., Maor, G., Youdim, M. B. H., & Mandel, S. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00490.x · Cited by 567 · see citing works

Tissue Distribution of Quercetin in Rats and Pigs

de Boer, V. C. J., Dihal, A. A., van der Woude, H., Arts, I. C. W., Wolffram, S., Alink, G. M., Rietjens, I. M. C. M., Keijer, J., & Hollman, P. C. H. (2005) · Journal of Nutrition · doi:10.1093/jn/135.7.1718 · Cited by 519 · see citing works

Isoflavones: estrogenic activity, biological effect and bioavailability

Vitale, D. C., Piazza, C., Melilli, B., Drago, F., & Salomone, S. (2012) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-012-0112-y · Cited by 500 · see citing works

Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease

Zbarsky, V., Datla, K. P., Parkar, S., Rai, D. K., Aruoma, O. I., & Dexter, D. T. (2005) · Free Radical Research · doi:10.1080/10715760500233113 · Cited by 462 · see citing works

The Role of Autophagy in Parkinson's DiseasePreprint

Lynch-Day, M. A., Mao, K., Wang, K., Zhao, M., & Klionsky, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009357 · Cited by 459 · see citing works

Elusive roles for reactive astrocytes in neurodegenerative diseases

Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453 · see citing works

The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease

Calkins, M. J., Johnson, D. A., Townsend, J. A., Vargas, M. R., Dowell, J. A., Williamson, T. P., Kraft, A. D., Lee, J., Li, J., & Johnson, J. A. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2242 · Cited by 440 · see citing works

Involvement of Protein Kinase C Activation and Cell Survival/ Cell Cycle Genes in Green Tea Polyphenol (−)-Epigallocatechin 3-Gallate Neuroprotective Action

Levites, Y., Amit, T., Youdim, M. B. H., & Mandel, S. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202832200 · Cited by 417 · see citing works

The life of a cell: apoptosis regulation by the PI3K/PKB pathway

Duronio, V. (2008) · Biochemical Journal · doi:10.1042/bj20081056 · Cited by 392 · see citing works

Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3

Schroeter, H., Spencer, J. P. E., Rice-Evans, C. A., & WILLIAMS, R. J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580547 · Cited by 373 · see citing works

Current approaches to the treatment of Parkinson’s disease

Jankovic, J. J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2006 · Cited by 343 · see citing works

Habitual intake of dietary flavonoids and risk of Parkinson disease

Gao, X., Cassidy, A., Schwarzschild, M. A., Rimm, E. B., & Ascherio, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31824f7fc4 · Cited by 333 · see citing works

Neuroprotective Effects of Citrus Flavonoids

Hwang, S.-L., Shih, P., & Yen, G. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf204452y · Cited by 320 · see citing works

Soya–a dietary source of the non-steroidal oestrogen equol in man and animals

Axelson, M., Sjövall, J., Gustafsson, B. E., & Setchell, K. D. R. (1984) · Journal of Endocrinology · doi:10.1677/joe.0.1020049 · Cited by 307 · see citing works

Incidence and remaining lifetime risk of Parkinson disease in advanced age

Driver, J. A., Logroscino, G., Gaziano, J. M., & Kurth, T. (2009) · Neurology · doi:10.1212/01.wnl.0000341769.50075.bb · Cited by 298 · see citing works

Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats

Ishisaka, A., Ichikawa, S., Sakakibara, H., Piskula, M. K., Nakamura, T., Kato, Y., Ito, M., Miyamoto, K.-I., Tsuji, A., Kawai, Y., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.017 · Cited by 293 · see citing works

Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease

Filomeni, G., Graziani, I., Zio, D. D., Dini, L., Centonze, D., Rotilio, G., & Ciriolo, M. R. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.021 · Cited by 260 · see citing works

Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats

Karuppagounder, S. S., Madathil, S. K., Pandey, M., Haobam, R., Rajamma, U., & Mohanakumar, K. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.032 · Cited by 225 · see citing works

Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease

Datla, K. P., Christidou, M., Widmer, W. W., ROOPRAI, H. K., & Dexter, D. T. (2001) · Neuroreport · doi:10.1097/00001756-200112040-00053 · Cited by 224 · see citing works

Protective Effects of Green Tea Polyphenols in the 6-OHDA Rat Model of Parkinson’s Disease Through Inhibition of ROS-NO Pathway

Guo, S., Yan, J., Yang, T., Yang, X., Bézard, E., & Zhao, B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.020 · Cited by 221 · see citing works

Specific pathophysiological functions of JNK isoforms in the brain

Brecht, S., Kirchhof, R., Chromik, A. M., Willesen, M. G., Nicolaus, T., Raivich, G., Wessig, J., Waetzig, V., Goetz, M. E., Claussen, M. C., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03857.x · Cited by 219 · see citing works

How Protein Kinase C Activation Protects Nerve Cells from Oxidative Stress-Induced Cell Death

Maher, P. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-09-02929.2001 · Cited by 218 · see citing works

Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression

Rezai-Zadeh, K. P., Ehrhart, J. C., Bai, Y., Sanberg, P. R., Bickford, P. C., Tan, J. R., & Shytle, R. D. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-41 · Cited by 217 · see citing works

Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway

Lou, H., Xu, J., Wei, X., Shi, H., Ren, D., & Zhang, X. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.026 · Cited by 212 · see citing works

Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis

Anusha, C., Sumathi, T., & Joseph, L. D. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.03.016 · Cited by 209 · see citing works

Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain

Chauhan, N. B., Siegel, G. J., & Lee, J. M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00115-6 · Cited by 207 · see citing works

Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin

Cho, J. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02968255 · Cited by 205 · see citing works

Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro

Mu, X. L., He, G., Cheng, Y., Li, X., Xu, B., & Du, G. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.03.008 · Cited by 194 · see citing works

Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease

Ay, M., Luo, J. D., Langley, M. R., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14033 · Cited by 191 · see citing works

Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models

Kim, H. G., Ju, M. S., Shim, J. S., Kim, M. C., Lee, S., Huh, Y., Kim, S. Y., & Oh, M. S. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510000218 · Cited by 189 · see citing works

Rutin Protects Dopaminergic Neurons from Oxidative Stress in an Animal Model of Parkinson’s Disease

Khan, M. M., Raza, S. S., Javed, H., Ahmad, A., Khan, A., Islam, F., Safhi, M. M., & Islam, F. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9295-2 · Cited by 186 · see citing works

Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein

Schroeter, H., Williams, R. J., Matin, R., Iversen, L. L., & Rice-Evans, C. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00415-9 · Cited by 184 · see citing works

Neuroprotective Effects of Hesperidin, a Plant Flavanone, on Rotenone-Induced Oxidative Stress and Apoptosis in a Cellular Model for Parkinson’s Disease

Tamilselvam, K., Braidy, N., Manivasagam, T., Essa, M. M., Prasad, N. R., Karthikeyan, S., Thenmozhi, A. J., Subash, S., & Guillemin, G. J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/102741 · Cited by 183 · see citing works

Structural Characteristics of α-Synuclein Oligomers Stabilized by the Flavonoid Baicalein

Hong, D.-P., Fink, A. L., & Uversky, V. N. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.039 · Cited by 177 · see citing works

Green Tea Epigallocatechin 3-Gallate Accumulates in Mitochondria and Displays a Selective Antiapoptotic Effect Against Inducers of Mitochondrial Oxidative Stress in Neurons

Schroeder, E. K., Kelsey, N. A., Doyle, J., Breed, E. R., Bouchard, R. J., Loucks, F. A., Harbison, R. A., & Linseman, D. A. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2215 · Cited by 177 · see citing works

Baicalein Inhibits Formation of α‐Synuclein Oligomers within Living Cells and Prevents Aβ Peptide Fibrillation and Oligomerisation

Lu, J.-H., Ardah, M., Durairajan, S. S. K., Liu, L.-F., Xie, L.-X., Fong, W.-F. D., Hasan, M., Huang, J.-D., El-Agnaf, O., & Li, M. (2011) · ChemBioChem · doi:10.1002/cbic.201000604 · Cited by 170 · see citing works

Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice

Antunes, M. S., Goes, A. T. R., Boeira, S. P., Prigol, M., & Jessé, C. R. (2014) · Nutrition · doi:10.1016/j.nut.2014.03.024 · Cited by 162 · see citing works

Synaptic dysfunction in Parkinson's disease

Bagetta, V., Ghiglieri, V., Sgobio, C., Calabresi, P., & Picconi, B. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380493 · Cited by 159 · see citing works

Mitochondrial Dysfunction in Parkinson's Disease

Zhu, J., & Chu, C. T. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100363 · Cited by 158 · see citing works

Neuroprotective Effect of Kaempferol against a 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease

Li, S., & Pu, X. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1291 · Cited by 157 · see citing works

Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation

Chen, H.-Q., Jin, Z., Wang, X., Xu, X., Deng, L., & Zhao, J.-W. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.046 · Cited by 150 · see citing works

Dopaminergic pathway reconstruction by Akt/Rheb‐induced axon regeneration

Kim, S. R., Chen, X. M., Oo, T. F., Kareva, T., Yarygina, O., Wang, C., During, M. J., Kholodilov, N. G., & Burke, R. E. (2011) · Annals of Neurology · doi:10.1002/ana.22383 · Cited by 143 · see citing works

Neuroprotective effect of baicalein against MPTP neurotoxicity: Behavioral, biochemical and immunohistochemical profile

Cheng, Y., He, G., Mu, X. L., Zhang, T., Li, X., Hu, J., Xu, B., & Du, G. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.116 · Cited by 141 · see citing works

Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease

Liu, L.-X., Chen, W.-F., Xie, J., & Wong, M. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.10.005 · Cited by 139 · see citing works

Anti-neuroinflammatory Activity of Nobiletin on Suppression of Microglial Activation

Cui, Y., Wu, J., Jung, S., Park, D.-B., Maeng, Y., Hong, J. Y., Kim, S.-J., Lee, S.-R., Kim, S., Kim, S. J., et al. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1814 · Cited by 133 · see citing works

Equol, a Dietary Daidzein Gut Metabolite Attenuates Microglial Activation and Potentiates Neuroprotection In Vitro

Subedi, L., Ji, E., Shin, D., Jin, J., Yeo, J., & Kim, S. (2017) · Nutrients · doi:10.3390/nu9030207 · Cited by 133 · see citing works

Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson’s Disease

Xu, Y., Zhang, Y., Quan, Z., Wong, W., Guo, J., Zhang, R., Yang, Q., Dai, R., McGeer, P. L., & Qing, H. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1995-9 · Cited by 132 · see citing works

Molecular Mechanisms Underlying the Flavonoid-Induced Inhibition of α-Synuclein Fibrillation

Meng, X., Munishkina, L. A., Fink, A. L., & Uversky, V. N. (2009) · Biochemistry · doi:10.1021/bi900506b · Cited by 130 · see citing works

Identification of Cathepsin B as a Mediator of Neuronal Death Induced by Aβ-activated Microglial Cells Using a Functional Genomics Approach

Gan, L., Ye, S., Chu, A., Anton, K., Yi, S.-L., Vincent, V. A. M., von Schack, D., Chin, D. J., Murray, J. C., Lohr, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306183200 · Cited by 128 · see citing works

Apigenin and its impact on gastrointestinal cancers

Lefort, É. C., & Blay, J. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200424 · Cited by 128 · see citing works

Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression

Wu, L.-H., Lin, C., Lin, H., Liu, Y.-S., Wu, C. Y.-J., Tsai, C., Chang, P.-C., Yeh, W., & Lu, D. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9042-9 · Cited by 128 · see citing works

Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity

Magalingam, K. B., Radhakrishnan, A. K., & Haleagrahara, N. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1375 · Cited by 123 · see citing works

Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice

Yabuki, Y., Ohizumi, Y., Yokosuka, A., Mimaki, Y., & Fukunaga, K. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.051 · Cited by 118 · see citing works

Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF

Beck, M., Flachenecker, P., Magnus, T., Giess, R., Reiners, K., Toyka, K. V., & Naumann, M. K. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510028412 · Cited by 117 · see citing works

Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum

Haleagrahara, N., Siew, C. J., Mitra, N. K., & Kumari, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.06.021 · Cited by 117 · see citing works

Case-Control Study of Early Life Dietary Factors in Parkinson's Disease

Golbe, L. I., Farrell, T. M., & Davis, P. H. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520360068014 · Cited by 115 · see citing works

Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease

Lv, C., Hong, T., Yang, Z. Y., Zhang, Y., Wang, L., Dong, M., Zhao, J., Mu, J., & Meng, Y. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/928643 · Cited by 113 · see citing works

Baicalein attenuates astroglial activation in the 1‐methyl‐4‐phenyl‐1,2,3,4‐tetrahydropyridine‐induced Parkinson's disease model by downregulating the activations of nuclear factor‐κB, ERK, and JNK

Lee, E., Park, H. R., Ji, S. T., Lee, Y., & Lee, J. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23307 · Cited by 108 · see citing works

Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease

Hu, Q. Z., Uversky, V. N., Huang, M., Kang, H., Xu, F., Liu, X., Lian, L., Liang, Q., Jiang, H., Liu, A., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.008 · Cited by 107 · see citing works

AAV transduction of dopamine neurons with constitutively active rheb protects from neurodegeneration and mediates axon regrowth

Kim, S. R., Kareva, T., Yarygina, O., Kholodilov, N., & Burke, R. E. (2012) · Molecular Therapy · doi:10.1038/mt.2011.213 · Cited by 107 · see citing works

Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat

Zhang, L., Zhao, H., Zhang, X., Chen, L., Zhao, X., Bai, X. H., & Zhang, J. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.04.009 · Cited by 106 · see citing works

Regional Alterations of Protein Kinase C Activity Following Transient Cerebral Ischemia: Effects of Intraischemic Brain Temperature Modulation

Busto, R., Globus, M. Y. ‐., Neary, J. T., & Ginsberg, M. D. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63031095.x · Cited by 105 · see citing works

ATF6alpha Promotes Astroglial Activation and Neuronal Survival in a Chronic Mouse Model of Parkinson’s Disease

Hashida, K., Kitao, Y., Sudo, H., Awa, Y., Maeda, S., Mori, K., Takahashi, R., Iinuma, M., & Hori, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047950 · Cited by 103 · see citing works

Naringin Protects against Rotenone-induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells

Kim, H., Song, J. Y., Park, H., Park, H., Yun, D. H., & Chung, J. (2009) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2009.13.4.281 · Cited by 100 · see citing works

Neuroprotective Properties of the Standardized Extract fromCamellia sinensis(Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson’s Disease

Pinto, N. B., Alexandre, B. D. S., Neves, K. R. T., Silva, A. H., Leal, L. K. A. M., & Viana, G. S. D. B. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/161092 · Cited by 99 · see citing works

Genistein protects dopaminergic neurons by inhibiting microglial activation

Wang, X., Chen, S., Ma, G., Ye, M., & Lü, G. (2005) · Neuroreport · doi:10.1097/00001756-200502280-00013 · Cited by 99 · see citing works

Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: Implications for Parkinson’s disease and protection by polyphenols

Vauzour, D., Ravaioli, G. M., Vafeiadou, K., Rodriguez‐Mateos, A., Angeloni, C., & Spencer, J. P. E. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.011 · Cited by 96 · see citing works

Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP+-treated nigrostriatal dopaminergic system in vivo

Hung, K.-C., Huang, H.-J., Wang, Y.-T., & Lin, A. M.-Y. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.040 · Cited by 96 · see citing works

Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease

Leem, E., Nam, J. H., Jeon, M., Shin, W.-H., Won, S.-Y., Park, S., Choi, M., Jin, B. K., Jung, U. J., & Kim, S. R. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.03.006 · Cited by 96 · see citing works

Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism

Roghani, M., Akram, N., Nadoushan, M. J., Kiasalari, Z., Khalili, M., & Baluchnejadmojarad, T. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.06.004 · Cited by 93 · see citing works

The “Memory Kinases”

Sun, M., & Alkon, D. L. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-420170-5.00002-7 · Cited by 92 · see citing works

Kappa opioids promote the proliferation of astrocytes via Gβγ and β‐arrestin 2‐dependent MAPK‐mediated pathways

McLennan, G., Kiss, A., Miyatake, M., Belcheva, M. M., Chambers, K. T., Pozek, J. J., Mohabbat, Y., Moyer, R. A., Bohn, L., & Coscia, C. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05745.x · Cited by 89 · see citing works

Inhibition of inducible nitric oxide synthase expression and cell death by (−)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease

Kim, J., Kim, J.-M., Jeong-Ja, O., & Jeon, B. S. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.01.042 · Cited by 88 · see citing works

Baicalein reduces E46K α‐synuclein aggregation in vitro and protects cells against E46K α‐synuclein toxicity in cell models of familiar Parkinsonism

Jiang, M., Porat‐Shliom, Y., Pei, Z., Cheng, Y., Xiang, L., Sommers, K., Li, Q., Gillardon, F., Hengerer, B., Berlinicke, C. A., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06752.x · Cited by 86 · see citing works

Anti-Inflammatory Role of the Isoflavone Diadzein in Lipopolysaccharide-Stimulated Microglia: Implications for Parkinson’s Disease

Chinta, S. J., Ganesan, A., Rodrigues, P. R., Lithgow, G. J., & Andersen, J. K. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9328-5 · Cited by 85 · see citing works

Myricetin attenuated MPP+-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells

Zhang, K., Ma, Z., Wang, J., Xie, A., & Xie, J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.021 · Cited by 84 · see citing works

Phytochemicals as future drugs for Parkinson’s disease: a comprehensive review

Shahpiri, Z., Bahramsoltani, R., Farzaei, M. H., Farzaei, F., & Rahimi, R. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0004 · Cited by 84 · see citing works

Luteolin Modulates 6-Hydroxydopamine-Induced Transcriptional Changes of Stress Response Pathways in PC12 Cells

Hu, L.-W., Yen, J.-H., Shen, Y., Wu, K.-Y., & Wu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097880 · Cited by 81 · see citing works

Neuroprotective effect of genistein in 6‐hydroxydopamine Hemi‐parkinsonian rat model

Baluchnejadmojarad, T., Roghani, M., Nadoushan, M. J., & Bagheri, M. (2008) · Phytotherapy Research · doi:10.1002/ptr.2564 · Cited by 81 · see citing works

Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals

Koh, S. H., Kwon, H., Kim, K. S., Kim, J., Kim, M.-H., Yu, H.-J., Kim, M., Lee, K. W., Rok, B., Jung, H. K., et al. (2004) · Toxicology · doi:10.1016/j.tox.2004.05.008 · Cited by 81 · see citing works

Neuroprotective Constituents from Hedyotis diffusa

Kim, Y., Park, E., Kim, J., Kim, Y.-B., Kim, S. R., & Kim, Y. C. (2000) · Journal of Natural Products · doi:10.1021/np000327d · Cited by 80 · see citing works

Induction of GDNF and BDNF by hRheb(S16H) Transduction of SNpc Neurons: Neuroprotective Mechanisms of hRheb(S16H) in a Model of Parkinson’s Disease

Nam, J. H., Leem, E., Jeon, M.-T., Jeong, K. H., Park, J.-W., Jung, U. J., Kholodilov, N., Burke, R. E., Jin, B. K., & Kim, S. R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8729-2 · Cited by 76 · see citing works

Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury

Pan, T., Fei, J., Zhou, X., Jankovic, J. J., & Le, W. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02347-0 · Cited by 74 · see citing works

Protective effects of flavonol isoquercitrin, against 6-hydroxy dopamine (6-OHDA) - induced toxicity in PC12 cells

Magalingam, K. B., Radhakrishnan, A. K., & Haleagrahara, N. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-49 · Cited by 73 · see citing works

Structure–activity relationship of flavonoids derived from medicinal plants in preventing methylmercury-induced mitochondrial dysfunction

Franco, J. L., Posser, T., Missau, F. C., Pizzolatti, M. G., Santos, A. R. S., Souza, D. O., Aschner, M., da Rocha, J. B. T., Dafré, A. L., & Farina, M. (2010) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2010.07.003 · Cited by 72 · see citing works

Naringin treatment induces neuroprotective effects in a mouse model of Parkinson's disease in vivo, but not enough to restore the lesioned dopaminergic system

Kim, H. D., Jeong, K. H., Jung, U. J., & Kim, S. R. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.10.013 · Cited by 72 · see citing works

Akt as a Victim, Villain and Potential Hero in Parkinson’s Disease Pathophysiology and Treatment

Greene, L. A., Levy, O., & Malagelada, C. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9671-8 · Cited by 68 · see citing works

Formation of Dopamine Adducts Derived from Brain Polyunsaturated Fatty Acids

Liu, X., Yamada, N., Maruyama, W., & Osawa, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805682200 · Cited by 64 · see citing works

Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat

Kiasalari, Z., Khalili, M., Baluchnejadmojarad, T., & Roghani, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1796-6 · Cited by 62 · see citing works

Baicalein Prevents 6-Hydroxydopamine-Induced Mitochondrial Dysfunction in SH-SY5Y Cells via Inhibition of Mitochondrial Oxidation and Up-Regulation of DJ-1 Protein Expression

Wang, Y., Yu, H., Pu, X., & Du, G. (2013) · Molecules · doi:10.3390/molecules181214726 · Cited by 61 · see citing works

Aggregation of α-synuclein in the pathogenesis of Parkinson’s disease

Iwatsubo, T. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1303-x · Cited by 61 · see citing works

Nobiletin Protects Dopaminergic Neurons in the 1-Methyl-4-Phenylpyridinium-Treated Rat Model of Parkinson's Disease

Jeong, K. H., Jeon, M., Kim, H. D., Jung, U. J., Jang, M. C., Chu, J. W., Yang, S. J., Choi, I. Y., Choi, M.-S., & Kim, S. R. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3241 · Cited by 58 · see citing works

Neurodegenerative Pathways in Parkinsons Disease: Therapeutic Strategies

Cardoso, S. M., Moreira, P. I., Agostinho, P. M., Pereira, C., & Oliveira, C. R. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054546072 · Cited by 55 · see citing works

Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson’s disease: Possible involvement of PI3K/ERβ signaling

Baluchnejadmojarad, T., Jamali-Raeufy, N., Zabihnejad, S., Rabiee, N., & Roghani, M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.002 · Cited by 54 · see citing works

Effects of luteolin on learning acquisition in rats: Involvement of the central cholinergic system

Tsai, F., Peng, W., Wang, W.-H., Wu, C., Hsieh, C., Lin, Y., Feng, I.-C., & Hsieh, M. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.055 · Cited by 54 · see citing works

Mechanism of Anti-α-Synuclein Immunotherapy

Lee, J. S., & Lee, S. (2016) · Journal of Movement Disorders · doi:10.14802/jmd.15059 · Cited by 52 · see citing works

Baicalein ameliorated the upregulation of striatal glutamatergic transmission in the mice model of Parkinson's disease

Xue, X., Liu, H., Qi, L., Li, X., Guo, C., Gong, D., & Qu, H.-Q. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.02.004 · Cited by 49 · see citing works

Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats

Ma, Z., Wang, J., Jiang, H. F., Liu, T., & Xie, J. (2007) · Neuroreport · doi:10.1097/wnr.0b013e32821c51fe · Cited by 49 · see citing works

Low Dosage of Rasagiline and Epigallocatechin Gallate Synergistically Restored the Nigrostriatal Axis in MPTP-Induced Parkinsonism

Reznichenko, L., Kalfon, L., Amit, T., Youdim, M. B. H., & Mandel, S. A. (2010) · Neurodegenerative Diseases · doi:10.1159/000265946 · Cited by 48 · see citing works

Tissue distribution of naringenin conjugated metabolites following repeated dosing of naringin to rats

Lin, S.-P., Hou, Y., Tsai, S.-Y., Wang, M.-J., & Chao, P.-D. L. (2014) · Biomedicine · doi:10.7603/s40681-014-0016-z · Cited by 47 · see citing works

Baicalein Prevents 6-Hydroxydopamine-Induced Dopaminergic Dysfunction and Lipid Peroxidation in Mice

Im, H., Joo, W. S., Nam, E., Lee, E.-S., Hwang, Y.-J., & Kim, Y. S. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.sc0050014 · Cited by 47 · see citing works

Kaempferol Derivatives Prevent Oxidative Stress–Induced Cell Death in a DJ-1–Dependent Manner

Qu, W., Li, F., Kim, Y.-C., Ishikawa, S., Iguchi‐Ariga, S. M. M., Pu, X., & Ariga, H. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09045fp · Cited by 42 · see citing works

Myricitrin attenuates 6-hydroxydopamine-induced mitochondrial damage and apoptosis in PC12 cells via inhibition of mitochondrial oxidation

Wang, Y., Xuan, Z.-H., Tian, S., He, G., & Du, G. (2013) · Journal of Functional Foods · doi:10.1016/j.jff.2012.11.004 · Cited by 41 · see citing works

Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain

Kim, H. D., Jeong, K. H., Jung, U. J., & Kim, S. R. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2015.3581 · Cited by 41 · see citing works

Antioxidant and anti-inflammatory potential of hesperidin against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced experimental Parkinson′s disease in mice

Manivasagam, T., Nataraj, J., Tamilselvam, K., Essa, M., & Janakiraman, U. (2013) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/2231-0738.114875 · Cited by 38 · see citing works

Polychlorinated biphenyls impair blood–brain barrier integrity via disruption of tight junction proteins in cerebrum, cerebellum and hippocampus of female Wistar rats

Selvakumar, K., Prabha, R. L., Saranya, K., Bavithra, S., Krishnamoorthy, G., & Arunakaran, J. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327112464798 · Cited by 36 · see citing works

Myricitrin alleviates MPP+-induced mitochondrial dysfunction in a DJ-1-dependent manner in SN4741 cells

Cai, Z., Zeng, W., Tao, K. X., Lu, F., Gao, G., & Yang, Q. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.060 · Cited by 36 · see citing works

Preventive effects of genistein on motor dysfunction following 6-hydroxydopamine injection in ovariectomized rats

Kyuhou, S.-I. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.045 · Cited by 27 · see citing works

Protein Kinase D1 (PKD1) Phosphorylation Promotes Dopaminergic Neuronal Survival during 6-OHDA-Induced Oxidative Stress

Asaithambi, A., Ay, M., Jin, H., Gosh, A., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096947 · Cited by 27 · see citing works

Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: effects on enzyme stability and activity

Royo, M., Fitzpatrick, P. F., & Daubner, S. C. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.11.007 · Cited by 26 · see citing works

Molecular cloning, epigenetic regulation, and functional characterization of Prkd1 gene promoter in dopaminergic cell culture models of Parkinson's disease

Ay, M., Jin, H., Harischandra, D. S., Asaithambi, A., Kanthasamy, A., Anantharam, V., & Kanthasamy, A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13261 · Cited by 22 · see citing works

Preventive Effects of Soy Meal (±Isoflavone) on Spatial Cognitive Deficiency and Body Weight in an Ovariectomized Animal Model of Parkinson's Disease

Sarkaki, A., Badavi, M., Aligholi, H., & Moghaddam, A. Z. (2009) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2009.1338.1345 · Cited by 22 · see citing works

Antioxidant and Anti-Inflammatory Effects of Citrus Flavonoid Hesperetin: Special Focus on Neurological Disorders

Khan, A., Ikram, M. A., Hahm, J. R., & Kim, M. O. (2020) · Antioxidants · doi:10.3390/antiox9070609 · Cited by 258 · see citing works

Possible Side Effects of Polyphenols and Their Interactions with Medicines

Duda‐Chodak, A., & Tarko, T. (2023) · Molecules · doi:10.3390/molecules28062536 · Cited by 244 · see citing works

The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms

Chiang, M., Tsai, T., & Wang, C.-J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076328 · Cited by 233 · see citing works

Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action

Bellavite, P. (2023) · Antioxidants · doi:10.3390/antiox12020280 · Cited by 217 · see citing works

Polyphenols in Parkinson’s Disease: A Systematic Review of In Vivo Studies

Kujawska, M., & Jodynis‐Liebert, J. (2018) · Nutrients · doi:10.3390/nu10050642 · Cited by 178 · see citing works

Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age

Payne, A., Nahashon, S. N., Taka, E., Adinew, G. M., & Soliman, K. F. A. (2022) · Biomolecules · doi:10.3390/biom12030371 · Cited by 171 · see citing works

Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease

Açar, Y., Ağagündüz, D., Cicco, P. D., & Capasso, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115788 · Cited by 134 · see citing works

Control of Reactive Oxygen Species for the Prevention of Parkinson’s Disease: The Possible Application of Flavonoids

Kim, T. Y., Leem, E., Lee, J. M., & Kim, S. R. (2020) · Antioxidants · doi:10.3390/antiox9070583 · Cited by 128 · see citing works

SIRT3 activator honokiol ameliorates surgery/anesthesia‐induced cognitive decline in mice through anti‐oxidative stress and anti‐inflammatory in hippocampus

Ye, J., Chen, L., Lu, Y., Lei, S., Peng, M., & Xia, Z. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13053 · Cited by 104 · see citing works

Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress

Cui, X., Lin, Q.-L., & Liang, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00209 · Cited by 95 · see citing works

Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation

Johnson, S. L., Kirk, R. D., DaSilva, N. A., Ma, H., Seeram, N. P., & Bertin, M. J. (2019) · Metabolites · doi:10.3390/metabo9040078 · Cited by 100 · see citing works

Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease

Franco, G. A., Interdonato, L., Cordaro, M., Cuzzocrea, S., & Paola, R. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087318 · Cited by 100 · see citing works

The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline

Melrose, J. (2023) · Antioxidants · doi:10.3390/antiox12030663 · Cited by 95 · see citing works

Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications

Angelopoulou, E., Pyrgelis, E.-S., & Piperi, C. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104612 · Cited by 93 · see citing works

The Anti-Neuroinflammatory Role of Anthocyanins and Their Metabolites for the Prevention and Treatment of Brain Disorders

Henriques, J. F., Serra, D., Dinis, T. C. P., & Almeida, L. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228653 · Cited by 93 · see citing works

The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment

Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88 · see citing works

Role of Dietary Supplements in the Management of Parkinson’s Disease

Ciulla, M., Marinelli, L., Cacciatore, I., & Stefano, A. D. (2019) · Biomolecules · doi:10.3390/biom9070271 · Cited by 92 · see citing works

Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives

Maan, G., Sikdar, B., Kumar, A., Shukla, R., & Mishra, A. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200416085330 · Cited by 85 · see citing works

Benefits of hesperidin in central nervous system disorders: a review

Kim, J., Wie, M., Ahn, M., Tanaka, A., Matsuda, H., & Shin, T. (2019) · Anatomy & Cell Biology · doi:10.5115/acb.19.119 · Cited by 77 · see citing works

Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol

Rahul, R., & Siddique, Y. H. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210129122033 · Cited by 71 · see citing works

Insight into Tea Flavonoids: Composition and Chemistry

He, H., Wei, K., Yin, J., & Yang, Y. (2020) · Food Reviews International · doi:10.1080/87559129.2020.1721530 · Cited by 68 · see citing works

Effects of Astragalus polysaccharide on the solubility and stability of 15 flavonoids

Liu, F., Sun, L., You, G., Liu, H., Ren, X., & Wang, M. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.148 · Cited by 63 · see citing works

Endocrine disruptors of inhibiting testicular 3β-hydroxysteroid dehydrogenase

Zhang, S., Mo, J., Wang, Y., Ni, C., Li, X., Zhu, Q., & Ge, R. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.027 · Cited by 61 · see citing works

Role of Plant Phytochemicals: Resveratrol, Curcumin, Luteolin and Quercetin in Demyelination, Neurodegeneration, and Epilepsy

Grabarczyk, M., Szczepańska, W., Czpakowska, J., Smolińska, E., Szychowska, A., Glabinski, A. R., & Szpakowski, P. (2024) · Antioxidants · doi:10.3390/antiox13111364 · Cited by 61 · see citing works

Neuroprotective effects of catechin and quercetin in experimental Parkinsonism through modulation of dopamine metabolism and expression of IL-1β, TNF-α, NF-κB, IκKB, and p53 genes in male Wistar rats

Josiah, S. S., Famusiwa, C. D., Crown, O. O., Lawal, A. O., Olaleye, M. T., Akindahunsi, A. A., & Akinmoladun, A. C. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.03.004 · Cited by 58 · see citing works

The role of nutrition on Parkinson’s disease: a systematic review

Bianchi, V. E., Rizzi, L., & Somaa, F. A. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2073107 · Cited by 57 · see citing works

Nrf2 as a potential target for Parkinson’s disease therapy

Niu, Y., Zhang, J., & Dong, M. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02071-5 · Cited by 54 · see citing works

An update on the advances in chromone and the derivatives synthesis based on the key chromone annulation of o-hydroxyaryl enaminones

Mao, L., Liu, Y., & Wan, J. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110784 · Cited by 54 · see citing works

Natural pigments: innovative extraction technologies and their potential application in health and food industries

Masyita, A., Hardinasinta, G., Astuti, A. D., Firdayani, F., Mayasari, D., Hori, A., Nisha, I. N. A., Nainu, F., & Kuraishi, T. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1507108 · Cited by 64 · see citing works

Dietary Polyphenols in Metabolic and Neurodegenerative Diseases: Molecular Targets in Autophagy and Biological Effects

García-Aguilar, A., Palomino, O. M., Benito, M., & Guillén, C. (2021) · Antioxidants · doi:10.3390/antiox10020142 · Cited by 52 · see citing works

Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson’s Disease

McCarty, M. F., & Lerner, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103624 · Cited by 51 · see citing works

Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders

Salari, A. M. N., Rasoulizadeh, Z., Shabgah, A. G., Vakili‐Ghartavol, R., Sargazi, G., & Navashenaq, J. G. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3964 · Cited by 50 · see citing works

Curcumin: A therapeutic potential in ageing-related disorders

Vaiserman, A. M., Koliada, A. K., Zayachkivska, A., & Lushchak, O. V. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100226 · Cited by 44 · see citing works

The promising role of natural products in Alzheimer's disease

da Rosa, M. M., de Amorim, L. C., Alves, J. V. D. O., Aguiar, I. F. D. S., Oliveira, F. G. D. S., da Silva, M. V., & dos Santos, M. T. C. (2022) · Brain Disorders · doi:10.1016/j.dscb.2022.100049 · Cited by 51 · see citing works

Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson’s disease: interplay between nuclear factor-kappa β and cathepsin B

Hassan, D. M., El-Kamel, A. H., Allam, E. A., Bakr, B. A., & Ashour, A. A. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01407-7 · Cited by 44 · see citing works

The (Poly)phenolic Profile of Separate Winery By-Products Reveals Potential Antioxidant Synergies

Costa‐Pérez, A., Medina, S., Sánchez‐Bravo, P., Domínguez‐Perles, R., & García‐Viguera, C. (2023) · Molecules · doi:10.3390/molecules28052081 · Cited by 43 · see citing works

Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases

Li, Q., Xing, S., Chen, Y., Liao, Q., Li, Q., Liu, Y., He, S., Feng, F., Chen, Y., Zhang, J., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111862 · Cited by 43 · see citing works

The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach

So, Y.-J., Lee, J.-U., Yang, G.-S., Yang, G., Kim, S. W., Lee, J., & Kim, J.-U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021071 · Cited by 41 · see citing works

Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease

Talebi, M., Kakouri, E., Talebi, M., Tarantilis, P. Α., Farkhondeh, T., İlgün, S., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1923479 · Cited by 39 · see citing works

The Role of Nutraceuticals and Functional Foods in Mitigating Cellular Senescence and Its Related Aspects: A Key Strategy for Delaying or Preventing Aging and Neurodegenerative Disorders

Ristori, S., Bertoni, G., Bientinesi, E., & Monti, D. (2025) · Nutrients · doi:10.3390/nu17111837 · Cited by 42 · see citing works

Kaempferol Has Potent Protective and Antifibrillogenic Effects for α-Synuclein Neurotoxicity In Vitro

Inden, M., Takagi, A., Kitai, H., Ito, T., Kurita, H., Honda, R. P., Kamatari, Y. O., Nozaki, S., Wen, X., Hijioka, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111484 · Cited by 36 · see citing works

5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease

Badillo‐Ramírez, I., Saniger, J. M., & Rivas-Arancibia, S. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104514 · Cited by 36 · see citing works

Effectiveness of Flavonoid-Rich Diet in Alleviating Symptoms of Neurodegenerative Diseases

Szulc, A., Wiśniewska, K., Żabińska, M., Gaffke, L., Szota, M., Olendzka, Z., Węgrzyn, G., & Pierzynowska, K. (2024) · Foods · doi:10.3390/foods13121931 · Cited by 36 · see citing works

Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases

Okoduwa, S. I. R., Abdulwaliyu, I., Igiri, B. E., Arekemase, S. O., Okoduwa, U. J., Itiat, J. F., Egbule, M. N., & Mustapha, R. A. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100558 · Cited by 32 · see citing works

Search for safer and potent natural inhibitors of Parkinson's disease

Khan, S. T., Ahmed, S., Gul, S., Khan, A., & Al‐Harrasi, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105135 · Cited by 32 · see citing works

Beneficial Role of Vitexin in Parkinson’s Disease

Mustapha, M., & Taib, C. N. M. (2023) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2023.30.2.2 · Cited by 32 · see citing works

Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?

Ward, R., Dexter, D., Martín-Bastida, A., & Crichton, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073338 · Cited by 28 · see citing works

MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus

Wang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062953 · Cited by 28 · see citing works

Phytomolecules as Alzheimer's therapeutics: A comprehensive review

Hussain, M. K., Ahmad, M., Khatoon, S., Khan, M. V., Azmi, S., Arshad, M., Ahamad, S., & Saquib, M. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117401 · Cited by 27 · see citing works

Total flavonoids of Astragalus membranaceus protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice by inhibiting ferroptosis through SLC7A11/GPX-4 signaling pathway

Gao, Z., Wang, G., Chen, Y., Yuan, W., Cai, J., Feng, A., Fang, J., Xu, Q., & Wu, X. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250035 · Cited by 26 · see citing works

α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson’s disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway

Huang, B., Hu, G., Zong, X., Yang, S., He, D., Gao, X., & Liu, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109698 · Cited by 26 · see citing works

Protective Effects of Polyphenol-Rich Extracts against Neurotoxicity Elicited by Paraquat or Rotenone in Cellular Models of Parkinson’s Disease

Tambe, M. A., Jacquet, A. D. R., Strathearn, K. E., Hensel, J. A., Colon, B. D., Chandran, A., Yousef, G. G., Grace, M. H., Ferruzzi, M. G., Wu, Q., et al. (2023) · Antioxidants · doi:10.3390/antiox12071463 · Cited by 26 · see citing works

Anthocyanins: Plant-based flavonoid pigments with diverse biological activities

Patra, S., Makhal, P. N., Jaryal, S., More, N., & Kaki, V. R. (2022) · International Journal of Plant Based Pharmaceuticals · doi:10.62313/ijpbp.2022.22 · Cited by 24 · see citing works

Myricetin reduces cytotoxicity by suppressing hepcidin expression in MES23.5 cells

Deng, H., Liu, S., Pan, D., Jia, Y., & Ma, Z. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300461 · Cited by 23 · see citing works

Therapeutic Potential of Polyscias fruticosa (L.) Harms Leaf Extract for Parkinson’s Disease Treatment by Drosophila melanogaster Model

Ly, H. T., Nguyen, T. T. H., Le, V. M., Lam, B. T., Trinh, T. T., & Thảo, Đ. T. P. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5262677 · Cited by 23 · see citing works

Targeting calcium homeostasis and impaired inter-organelle crosstalk as a potential therapeutic approach in Parkinson's disease

Kaur, S., Sehrawat, A., Mastana, S. S., Kandimalla, R. J. L., Sharma, P. K., Bhatti, G. K., & Bhatti, J. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121995 · Cited by 23 · see citing works

Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease

Pandey, S. N., Singh, G., Semwal, B. C., Gupta, G., Alharbi, K. S., Almalki, W. H., Albratty, M., Najmi, A., & Meraya, A. M. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14426 · Cited by 22 · see citing works

Antioxidant responses driven by Hesperetin and Hesperidin counteract Parkinson's disease-like phenotypes in Drosophila melanogaster

Adedara, A. O., Bressan, G. N., dos Santos, M. M., Fachinetto, R., Abolaji, A. O., & Barbosa, N. V. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.02.006 · Cited by 22 · see citing works

Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson’s Disease

Behl, T., Kaur, G., Sehgal, A., Zengin, G., Singh, S., Ahmadi, A., & Bungău, S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210524152817 · Cited by 13 · see citing works

Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson’s Disease

Rakowski, M., Lekki-Porębski, S. A., & Grzelak, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073625 · Cited by 20 · see citing works

Relationship of Curcumin with Aging and Alzheimer and Parkinson Disease, the Most Prevalent Age-Related Neurodegenerative Diseases: A Narrative Review

Türer, B. Y., & Şanlıer, N. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae079 · Cited by 21 · see citing works

A feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue and fatigability in people with Parkinson's (pwP)

Coe, S., Andreoli, D., George, M., Collett, J., Reed, A., Cossington, J., Izadi, H., Dixon, A., Mansoubi, M., & Dawes, H. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.01.023 · Cited by 19 · see citing works

Perspective: Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin

McCarty, M. F., & Lerner, A. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa112 · Cited by 17 · see citing works

The Anthocyanidin Peonidin Interferes with an Early Step in the Fibrillation Pathway of α-Synuclein and Modulates It toward Amorphous Aggregates

Verma, G., & Bhat, R. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00726 · Cited by 16 · see citing works

Protection from the Pathogenesis of Neurodegenerative Disorders, including Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Huntington’s Disease, and Parkinson’s Diseases, through the Mitigation of Reactive Oxygen Species

Madireddy, S., & Madireddy, S. (2019) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001026 · Cited by 16 · see citing works

Comprehensive review of Urtica dioica L. (Urticaceae) phytochemistry and anti-inflammatory properties

Parente, R., Paiva‐Santos, A. C., Cabral, C., & Costa, G. (2024) · Phytochemistry Reviews · doi:10.1007/s11101-024-09980-6 · Cited by 18 · see citing works

Alzheimer, Parkinson, dementia, and phytochemicals: insight review

Başak, C. A. N., & Şanlıer, N. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2299340 · Cited by 16 · see citing works

Food and Food Waste Antioxidants: Could They Be a Potent Defence against Parkinson’s Disease?

Cannas, C., Lostia, G., Serra, P. A., Peana, A. T., & Migheli, R. (2024) · Antioxidants · doi:10.3390/antiox13060645 · Cited by 14 · see citing works

Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression

Kopalli, S. R., Behl, T., Kyada, A., Rekha, M. M., Kundlas, M., Rani, P., Nathiya, D., Naidu, K. S., Gulati, M., Bhise, M. R., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.02.007 · Cited by 15 · see citing works

Nutrigenomic modification induced by anthocyanin-rich bilberry extract in the hippocampus of ApoE-/- mice

Milenković, D., Krga, I., Dinel, A., Morand, C., Layé, S., & Castanon, N. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104609 · Cited by 14 · see citing works

Neuroprotective Properties of Rutin Hydrate against Scopolamine-Induced Deficits in BDNF/TrkB/ERK/CREB/Bcl2 Pathways

Sreelatha, I., Choi, G.-Y., Lee, I.-S., Omkaram, I., Lee, H., Park, Y.-N., Lee, C.-W., Yang, I., Maeng, S., & Park, J. H. (2024) · Neurology International · doi:10.3390/neurolint16050082 · Cited by 13 · see citing works

Electrosynthesized Poly(o-aminophenol) Films as Biomimetic Coatings for Dopamine Detection on Pt Substrates

Ciriello, R., Graziano, M., Bianco, G. L., & Guerrieri, A. (2021) · Chemosensors · doi:10.3390/chemosensors9100280 · Cited by 13 · see citing works

Synergistic Neuroprotective Effect of Endogenously-Produced Hydroxytyrosol and Synaptic Vesicle Proteins on Pheochromocytoma Cell Line against Salsolinol

Manzoor, R., Rasool, A., Ahmed, M., Ullah, K., Duru, L. N., Ma, H., & Deng, Y. (2020) · Molecules · doi:10.3390/molecules25071715 · Cited by 13 · see citing works

An assessment of the ameliorative role of hesperidin in Drosophila melanogaster model of cadmium chloride-induced toxicity

Asejeje, F. O., Ogunro, O. B., Asejeje, G. I., Adewumi, O. S., & Abolaji, A. O. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109500 · Cited by 12 · see citing works

From Diabetes to Degenerative Diseases: The Multifaceted Action of Metformin

Campagnoli, L. I. M., Varesi, A., Fahmideh, F., Hakimizad, R., Petkovic, P., Barbieri, A., Marchesi, N., & Pascale, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199748 · Cited by 11 · see citing works

Can Nutritional Adequacy Help Evade Neurodegeneration in Older Age? A Review

Ajibawo-Aganbi, U., Saleem, S., Khan, S. Z. A., Veliginti, S., Bastidas, M. V. P., Lungba, R. M., & Cancarevic, I. (2020) · Cureus · doi:10.7759/cureus.10921 · Cited by 11 · see citing works

The alleviative effect of Calendula officinalis L. extract against Parkinson’s disease-like pathology in zebrafish via the involvement of autophagy activation

Wang, M., Ye, H., Jiang, P., Liu, J., Wang, B., Zhang, S., Attila Gabor, S. I. K., Li, N., Liu, K., & Jin, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1153889 · Cited by 10 · see citing works

Flavonoids as anti-inflammatory and neuroprotective agents

Lee, H., Selvaraj, B., Yoo, K. Y., & Ko, S. (2020) · International Journal of Oral Biology · doi:10.11620/ijob.2020.45.2.33 · Cited by 10 · see citing works

Aza-Flavanone Diminishes Parkinsonism in the Drosophila melanogaster Parkin Mutant

Pant, C., Chakrabarti, M., Mendonza, J. J., Ganganna, B., Pabbaraja, S., & Bhadra, M. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00285 · Cited by 10 · see citing works

Review on Ehrlich Ascites Carcinoma in Mice and Cancer Treatment with Special Reference to The Potential Protective and Therapeutic Effects of Hesperidin Versus Cisplatin

Saleh, N., Allam, T. S., Abdelfattah, A., & El-Borai, N. B. (2022) · Journal of Current Veterinary Research · doi:10.21608/jcvr.2022.240866 · Cited by 9 · see citing works

Effects of aerobic exercise and dietary flavonoids on cognition: a systematic review and meta-analysis

Joseph, D. K., Ludin, A. F. M., Ibrahim, F. W., Azam, A. A., Roos, N. A. C., Shahar, S., & Rajab, N. F. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1216948 · Cited by 9 · see citing works

Synthesis and Monoamine Oxidase Inhibitory Activity of Halogenated Flavones

Castillo-Arellano, J. I., Stryker, Z. I., Wyatt, M. D., & León, F. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00573 · Cited by 9 · see citing works

Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications

Bertoni, G., Ristori, S., & Monti, D. (2026) · Cells · doi:10.3390/cells15080657 · Cited by 9 · see citing works

Optimizing Modifiable and Lifestyle-related Factors in the Prevention of Dementia Disorders with Special Reference to Alzheimer, Parkinson and Autism Diseases

Gupta, U. C., & Gupta, S. C. (2019) · Current Nutrition & Food Science · doi:10.2174/1573401315666190801120306 · Cited by 9 · see citing works

Cocoa Flavanols and the Aging Brain

Lalonde, R., & Strazielle, C. (2022) · Current Aging Science · doi:10.2174/1874609815666220819145845 · Cited by 9 · see citing works

State and perspectives on flavonoid neuroprotection against aminochrome-induced neurotoxicity

Silva, V., & Segura‐Aguilar, J. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.306082 · Cited by 9 · see citing works

Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism

Beserra‐Filho, J. I. A., Maria‐Macêdo, A., Silva‐Martins, S., Custódio‐Silva, A. C., Soares‐Silva, B., Silva, S. P., Lambertucci, R. H., Araújo, A. A. D. S., Angélica, M., Quintans‐Júnior, L. J., et al. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01032-2 · Cited by 8 · see citing works

Neuroprotective potential of quercetin as a nutraceutical targeting fused neuroinflammation in neurological disease

Kaushik, A., Chauhan, K., & Singh, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00029-9 · Cited by 8 · see citing works

Therapeutic Potential of Natural Flavonoids: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective on Parkinson's Disease

Giri, S., & Chandra, P. (2024) · Current Drug Therapy · doi:10.2174/0115748855292178240223100534 · Cited by 8 · see citing works

Pharmacodynamical research of extracts and compounds in traditional Chinese medicines for Parkinson's disease

Li, M., Wang, H., Bai, Y., Xiong, F., Wu, S., Bi, Q., Qiao, Y., Zhang, Y., Li, X., Feng, L., et al. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.106086 · Cited by 8 · see citing works

A comprehensive review of natural compounds and their structure–activity relationship in Parkinson’s disease: exploring potential mechanisms

Merghany, R. M., El-Sawi, S. A., Naser, A. F. A., Ezzat, S. M., Moustafa, S. F., & Meselhy, M. R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03462-4 · Cited by 8 · see citing works

Tea and Its Active Ingredients in Preventing and Alleviating Depression: A Comprehensive Review

Xiao, S., Li, Y., Jiang, H., Hou, S., Wang, Y., Wang, D., & Teng, J. (2025) · Foods · doi:10.3390/foods14122054 · Cited by 10 · see citing works

Therapeutic potential of Coumarin-polyphenolic acid hybrids in PD: Inhibition of α-Syn aggregation and disaggregation of preformed fibrils, leading to reduced neuronal inclusion formation

Wang, Z., Zhang, W., Xing, L.-Z., Zhao, Y., Xu, J. P., & Zhang, Y. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129618 · Cited by 8 · see citing works

Dietary Natural Flavonoids: Intervention for MAO ‐B Against Parkinson's Disease

Singh, A., Sinha, S., & Singh, N. K. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14619 · Cited by 7 · see citing works

Phytochemistry and Pharmacological Aspects of Apigenin: A Review

Bhardawaj, H., Vasudeva, N., & Sharma, S. (2022) · The Natural Products Journal · doi:10.2174/2210315512666220520150358 · Cited by 7 · see citing works

Effect of Flavonoids against Parkinson’s Disease

Varshney, H., & Siddique, Y. H. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249264078231214074107 · Cited by 7 · see citing works

Neuroprotective Role of Transchalcone in Parkinson‘s Disease through AMP-activated Protein Kinase-mediated Signaling Pathway

Cheng, Y., Hussain, S. A., Alrubie, T. M., & Zhang, X. (2024) · Journal of physiological investigation. · doi:10.4103/ejpi.ejpi-d-24-00083 · Cited by 7 · see citing works

A critical analysis on the concentrations of phenolic compounds tested using in vitro and in vivo Parkinson’s disease models

Perdigão, J. M., Teixeira, B. J. B., Carvalho-da-Silva, V., Prediger, R. D., Lima, R. R., & Rogez, H. L. G. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2171960 · Cited by 7 · see citing works

Neuroprotective Effect of Naturally Occurring Flavonoids

Mishra, S. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249344284241112184703 · Cited by 6 · see citing works

Possible Mitigating Effect of Nobiletin on Rotenone–Induced Parkinsonism in Male Albino Rat Model: Targeting Bmal1/Nrf2 Mediated Ferroptosis and Restoring Mitochondrial Mitophagy

El‐Khalik, S. R. A., AbuoHashish, N. A., Nasif, E., Arakeep, H. M., El‐Anwar, N., Yousef, D. M., & Ayad, N. H. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04438-3 · Cited by 6 · see citing works

Flavonoids – Their Preventer and Therapeutic Applications Against Parkinson’s Disease

(2013) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608057672113020010

Plant-Derived Natural Products Targeting Multiple Pathways as Potential Therapeutics in the Treatment of Parkinson’s Disease

Vijay, A., & Balakrishnan, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-0534-8_14

Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease

Açar, Y., Ağagündüz, D., Cicco, P. D., & Capasso, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115788 · Cited by 134 · see citing works

Control of Reactive Oxygen Species for the Prevention of Parkinson’s Disease: The Possible Application of Flavonoids

Kim, T. Y., Leem, E., Lee, J. M., & Kim, S. R. (2020) · Antioxidants · doi:10.3390/antiox9070583 · Cited by 128 · see citing works

Therapeutic Potential of Natural Flavonoids: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective on Parkinson's Disease

Giri, S., & Chandra, P. (2024) · Current Drug Therapy · doi:10.2174/0115748855292178240223100534 · Cited by 8 · see citing works